Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -29.24% vs 1,830.35% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 5.21% vs 125.26% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -2.56% vs 140.04% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 200.00% vs -80.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Shijiazhuang Yiling Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -29.24% vs 1,830.35% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -19.81% vs -27.23% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 5.21% vs 125.26% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 51.80% vs -44.05% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -2.56% vs 140.04% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 26.26% vs -26.07% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 200.00% vs -80.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -97.14% vs 7.14% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






